Jodid Draselný Serb (Potassium Iodide)

Potassium iodide releases stable iodide ions that are taken up by the thyroid via the sodium‑iodide symporter. By flooding the gland with non‑radioactive iodide, it saturates the organ, thereby competitively inhibiting the uptake and incorporation of radioactive iodine and reducing radiation‑induced thyroid damage.

The appropriate dose of Jodid Draselný Serb is determined by a qualified prescriber based on the specific indication, patient age, weight, and clinical circumstances. Healthcare professionals set the regimen according to national guidelines and individual risk assessment.

Safety data for potassium iodide in pregnancy and lactation are limited. It should be used only when the potential benefit outweighs any possible risk to the fetus or infant, and under close medical supervision. Pregnant or nursing individuals should discuss alternatives with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Jodid Draselný Serb contains potassium iodide, the same active ingredient found in most stable‑iodine tablets used for radiation emergencies. Compared with alternative iodine sources such as Lugol’s solution, potassium iodide offers a precise, single‑iodide dose with fewer additional components, making it the preferred choice for thyroid blockade in emergency protocols.

Store the product at ambient temperature, preferably below 25 °C, in its original packaging. Protect it from moisture, direct sunlight, and extreme heat. Keep the container tightly closed and out of reach of children to maintain product stability and potency.

Jodid Draselný Serb is taken orally, typically with water. The exact administration schedule—such as single‑dose or repeated dosing—depends on the clinical indication and the prescriber's instructions. Patients should follow the healthcare professional’s guidance regarding timing relative to potential radioactive exposure.

Serious risks include severe allergic reactions (anaphylaxis), iodide‑induced hyperthyroidism or hypothyroidism, and rare dermatologic emergencies like Stevens‑Johnson syndrome. Individuals with pre‑existing thyroid disease, especially autoimmune thyroiditis, should be monitored closely for rapid changes in thyroid function.

Contraindications include known hypersensitivity to potassium iodide or any component of the formulation, untreated hyperthyroidism, and certain thyroid disorders where excess iodine could exacerbate the condition. Patients with severe renal impairment should also avoid use unless specifically directed by a physician.